|
HS Code |
252570 |
| generic_name | Lurasidone |
| brand_names | Latuda |
| drug_class | Atypical antipsychotic |
| indications | Schizophrenia, Bipolar depression |
| route_of_administration | Oral |
| dosage_forms | Tablet |
| mechanism_of_action | Dopamine D2 and serotonin 5-HT2A receptor antagonist |
| half_life | 18-40 hours |
| pregnancy_category | Category B (US) |
| metabolism | Hepatic (CYP3A4-mediated) |
| common_side_effects | Somnolence, akathisia, nausea, parkinsonism, agitation |
| storage_conditions | Store at 20°C to 25°C (68°F to 77°F) |
As an accredited Lurasidone factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Lurasidone 40 mg tablets come in a white, opaque blister pack, boxed, labeled clearly with contents and a quantity of 30 tablets. |
| Shipping | Lurasidone is shipped as a prescription pharmaceutical substance in compliance with regulations for controlled drugs. It is securely packaged to prevent contamination, exposure, and damage. Shipping typically requires temperature control and documentation detailing contents and safety information. Carriers must follow all local and international transport guidelines for pharmaceutical products. |
| Storage | Lurasidone should be stored at room temperature, typically between 20°C to 25°C (68°F to 77°F), and protected from moisture, heat, and direct light. It must be kept in a tightly closed container, away from incompatible substances. Ensure the storage area is well-ventilated and medicine is kept out of reach of children and pets. Do not freeze or refrigerate. |
| Purity 99%: Lurasidone Purity 99% is used in the formulation of oral tablets, where enhanced therapeutic efficacy and reduced impurity profiles are achieved.Stability Temperature 25°C: Lurasidone Stability Temperature 25°C is used in ambient storage conditions, where maintained chemical integrity during shelf life is obtained.Molecular Weight 492.6 g/mol: Lurasidone Molecular Weight 492.6 g/mol is used in pharmacokinetic studies, where accurate dosing calculations and consistent absorption profiles are ensured.Solubility in Water 0.3 mg/mL: Lurasidone Solubility in Water 0.3 mg/mL is used in suspension preparations, where predictable dissolution rates and homogeneous distribution are critical.Particle Size D90 < 10 µm: Lurasidone Particle Size D90 < 10 µm is used in micronized formulations, where increased bioavailability and optimal absorption are provided.Melting Point 234°C: Lurasidone Melting Point 234°C is used in thermal processing during solid dosage manufacturing, where prevention of degradation and preservation of active content is achieved.pKa 7.5: Lurasidone pKa 7.5 is used in buffered tablet formulations, where improved gastrointestinal absorption and targeted delivery are accomplished.Assay ≥98%: Lurasidone Assay ≥98% is used in quality control testing, where high batch consistency and regulatory compliance are maintained.Optical Rotation -12° (c=1, methanol): Lurasidone Optical Rotation -12° (c=1, methanol) is used in chiral purity assessment, where assurance of stereochemical integrity is critical.Residual Solvents <0.05%: Lurasidone Residual Solvents <0.05% is used in injectable formulations, where reduced toxicity and improved patient safety are realized. |
Competitive Lurasidone prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Lurasidone stands out in the landscape of antipsychotic medications, especially for people living with schizophrenia and bipolar depression. Doctors have long turned to antipsychotics to help manage severe mental health conditions, yet each newer option comes with its own twist. Lurasidone has carved out a spot for itself based not just on clinical trial data, but on the real-world experiences of users and mental health professionals alike. The value of any medication weighs heavily on its ability to fit into people’s lives—not just on how neatly it fits into a textbook category. Too often, patients describe antipsychotic drugs as a double-edged sword: effective for mood or psychotic symptoms, but loaded with side effects. Lurasidone offers fresh hope that a medication might lift mood and clarity without dragging along as much baggage as its predecessors.
People who live with schizophrenia know the drill — daily medicine, careful diet, navigating the world with a brain that often lags behind what others take for granted. Lurasidone’s entry to the antipsychotic market gave some of my patients a chance to gain stability and keep a sense of themselves. One reason lurasidone gained attention lies in its effects on weight. Some older antipsychotics—including olanzapine and quetiapine—trigger appetite changes and hefty weight gain; those shifts, in turn, put folks at risk for diabetes and other health problems. Lurasidone does not zero out these problems, but its track record for triggering less weight gain makes a difference in everyday life. Whether clients want to walk their dog farther or manage their blood sugar without jumping through extra hoops, these outcomes matter in ways that statistics alone won’t show.
Side effects shape quality of life. In real conversations, people worry less about textbook symptom lists and more about how a medication will impact their sleep, sexual function, ability to work, and relationships. The old stereotype of the “zombified” patient on high-dose antipsychotics surfaces with distressing regularity. Lurasidone offers some reassurance—its impact on daily alertness, cognitive clarity, and movement disorders (like the tremors linked to older drugs) is different. More patients seem to keep up with work or studies, and the desire to avoid sleepiness or emotional flatness affects every dose. Although side effects still crop up—no medication escapes that fact—doctors and users now have a treatment option that doesn’t leave them choosing between sanity and dignity.
Lurasidone’s chemistry places it in the “atypical antipsychotic” group, alongside other familiar drugs like risperidone and aripiprazole. This family gets its name because it acts a bit differently on brain pathways compared to older antipsychotics, sometimes called “typicals” or “first-generation” drugs. These older medications mainly block dopamine. They help with positive symptoms like hallucinations and delusions but also hit motor control and other parts of the nervous system—hence the signature stiffness, tremor, and awkward gait some patients develop.
Lurasidone, by acting on both dopamine and serotonin receptors, balances this effect. Think of it as a traffic cop, smoothing out the rush of signals in the brain linked to both mood and perception. Many patients say they feel their “thinking clears up,” or describe a reduction in paranoia, suspiciousness, or mood swings. In both clinical settings and daily use, this sets the stage for better social interactions and a stronger shot at reaching personal goals. Lurasidone also addresses depressive symptoms, not just psychotic ones—which doctors see as a rare and valuable asset. Bipolar depression is hard to treat, and many medications miss the mark; people often cycle through several drugs before finding real relief.
Many people worry about the complexity of their medication regimens. Lurasidone comes in tablet form, easy to store and straightforward to take—usually once daily with food. Skipping the elaborate dosing schedules that haunt other treatment plans makes a difference. People juggling complicated lives need a medication they can realistically stick with, day after day. This once-a-day schedule often fits better into real routines, so people are more likely to take the medicine as prescribed and see lasting improvements.
Food matters with lurasidone—the body absorbs it much better when you take it with a meal. Doctors often explain that taking the tablet with at least a modest amount of calories can bump up the medicine’s effect, making it work as intended instead of just passing through. This fact shapes daily habits; some people set reminders alongside breakfast or dinner to keep things predictable. No one wants to lose ground just because they skipped lunch.
The market brims with antipsychotic options. They all pitch some promise of symptom control, but they differ in their consequences. Lurasidone stays leaner on the side of metabolic complications: its risk for substantial weight gain, blood sugar spikes, and long-term cholesterol problems rates lower than with some other antipsychotics. For people already fighting an uphill battle with motivation and physical well-being, this matters a lot. It lowers the risk of developing conditions that demand their own lifelong management, like type 2 diabetes or heart disease. Adults and teens alike raise these concerns, so it's not just a worry for older patients.
Cognitive function often gets overlooked in mental health care. Some medicines cloud thinking, slow recall, or sap energy, making learning or working a real challenge. Lurasidone stands out because it seems to preserve more mental sharpness—students and working adults tell their stories of being able to keep up with tasks they’d abandoned during other treatments. Conversations with teachers and job coaches back up these personal reports with real improvements in school performance and workplace attendance.
Starting lurasidone usually involves a low dose, which doctors gradually increase as needed. This stepwise adjustment helps people adjust to the medicine, avoiding the shock that can sometimes come with new drug regimens. Unlike some antipsychotics, nobody insists on hospitalization just to get started. Outpatient settings can work, and people keep their independence rather than giving it up at the outset. Lurasidone dosing often feels less rigid—I’ve seen it work well for various ages, with dose changes possible when the body or lifestyle changes. Pregnant people or those with liver or kidney issues will get more careful attention, but this is true for almost any medicine.
No two people respond exactly the same way. Some require higher doses, especially if symptoms return or refuse to fade. Side effects push some users to ask for changes or to switch entirely. But in a world where medication adherence often breaks down at the first sign of trouble, the ability to craft a plan that fits each person’s life means fewer interruptions and a stronger chance at lasting mental health recovery.
Every medication demands caution and respect. Lurasidone is no exception. Some people experience restlessness, especially right after a dose increase, or mild movement symptoms if the dose runs high. Nausea, sleep changes, and headaches affect a few patients—more so early on than over time. I’ve spoken with people who worried about agitation, but these reactions tend to recede with time and careful dose management.
What really draws people in, though, remains a lower risk for those notorious antipsychotic complications: the dramatic weight gain, constant hunger, or sedation that leaves folks feeling “out of it“ for whole evenings. Parents, partners, and caretakers keep a close watch for early warning signs like muscle rigidity or unusual movements, a hangover from decades of fear about movement disorders linked to old-school drugs. Yet the number of complaints I’ve heard about “feeling wooden” or “twitchy” stays lower on lurasidone compared to some alternatives.
The possibility of a rare side effect like increased prolactin or subtle changes to heart rhythm encourages regular checkups. Most psychiatrists order routine lab work and an occasional EKG, not out of fear, but to stay ahead of potential problems. Nobody likes surprises—solid communication between patient and provider keeps risk low and turns what could be a guesswork game into a working partnership.
Walking through the pharmacy shelf, the antipsychotic section bursts with competition — aripiprazole, quetiapine, risperidone, olanzapine, ziprasidone, and more. Patients who’ve tried these drugs often share war stories about cravings, metabolic headaches, and unforeseeable reactions. With lurasidone, the cut in appetite stimulation wins fans. People no longer set alarms to stop themselves from midnight refrigerator raids or ration snacks for fear of ballooning waistlines.
Sedation—a huge sticking point for many—complicates daily function. Friends describe the drag of medicines that guarantee sleep but cloud every waking moment: the feeling of walking through molasses, words sticking on the tongue, and ambition dissolving. Lurasidone leaves more people alert, with less fatigue holding them back from day-to-day choices. These subtle shifts mean more social interaction, a higher chance of returning to school or work, and, in time, a stronger social network.
Hormonal disruptions mark another difference. Some medicines affect reproductive health or drive embarrassing side effects like breast changes or unwanted lactation. Reports of these problems appear less often with lurasidone in my experience, which matters for patient dignity and self-image. Yet, as with any antipsychotic, regular follow-up and honest conversations with clinicians remain key—shame or confusion shouldn’t keep anyone from addressing problems as they arise.
Living with schizophrenia or bipolar depression rarely means just ticking boxes on a symptom list. Relationships, employment, and self-worth all take a hit, sometimes more than the basic illness. Medicines that lower barriers—or at least hold off new ones—nudge people toward healing beyond the clinical definition of “remission.” Lurasidone, by promoting alertness and curbing metabolic side effects, nudges people closer to a sense of normalcy and hope.
Physical health feeds back into mental health. People gain confidence when they hold steady at a healthy weight, slip into old jeans, or pass their annual checkup without alarm. The joy of movement and the pride in managing one’s body reinforce mental well-being, so a medicine that helps keep the body on track stands for more than just biochemistry. Doctors and care teams need to keep broadening their sights—seeing the person behind the prescription, not just the diagnosis.
In my own practice, I’ve watched people arrive at the clinic discouraged from trying a string of other antipsychotics. The standard worries apply—fear of “going back there,” uncertainty about new side effects, the risk of more weight gain or lost drive. Lurasidone doesn’t fix everything overnight, but it changes the conversation. Teens struggling with school find focus returns. Parents feel more confident in their ability to care for their family. Older adults describe feeling “more present.”
No drug stands alone without support. The clearest success comes when patients pair lurasidone with therapy, family involvement, and stable routines. Medications give a leg up, but human connection and structured support clinch the best results. Some patients call it a “piece of the puzzle,” not a magic bullet, but the piece most needed at the right moment. As a clinician, these are the moments that show a product’s real worth: not just in symptom scores, but in laughter, relationships, new jobs, and school graduations.
Good news travels fast, but access to new medications often lags for those who need them most. Lurasidone remains out of reach for some uninsured people or for those facing high copays and insurance hurdles. Generic options promise to ease the financial pinch, but navigation through insurance coverage and pharmacy supply chains can frustrate both patients and prescribers. More robust patient assistance programs and clearer communication from insurance companies would make a measurable difference.
Doctors, social workers, and advocacy groups all play a part. For everyone, it helps to have open conversations about cost, coverage, and sample programs. The more transparent plans become, the less disruption people experience when a new medicine might be right for them. The old fear of “We found the right drug, but you can’t get it” haunts many clinics but does not need to define the next chapter.
The rollout of any new psychiatric medication prompts hope and skepticism in equal measure. Before lurasidone, every new option felt weighed down by baggage or offered only minor gains. Therapists and psychiatrists waited to see if the lived experience matched up to the promise, and users held their breath for something better than the usual trade-offs. Years in, lurasidone has earned respect—not for miracles, but for meaningful, sustainable changes in daily life.
Mental health treatment works best not when a medication erases every problem, but when it gives people back their agency and dignity. Lurasidone does not make schizophrenia or bipolar depression disappear. It offers a steadier ground—a base for building relationships, exploring hobbies, chasing goals, and repairing what illness tried to take away. By reducing the weight gain, fatigue, and cognitive slowing so common with rival products, lurasidone helps people focus more on living and less on just getting by.
The journey of treating mental illness too often takes place in silence and shame. Sharing honest feedback and lessons about medicines like lurasidone helps chip away at that wall. Patients, family members, doctors, and advocates can learn from each story, adjusting expectations and strategies along the way. As a community, greater compassion and curiosity about how medications impact everyday life will always beat simple brand comparisons.
Continuous education matters. For every person just starting out, a strong partnership with knowledgeable healthcare providers goes a long way. Review options, monitor health, check in on side effects regularly, and invite loved ones to support the effort. Lurasidone earns its place in the tool kit not by being perfect, but by providing a new route to stability and self-determination.
Not every medicine finds its way onto the shortlist of treatments that affect people’s lives in practical, visible ways. Lurasidone stands out as an antipsychotic choice that offers hope for better health, stronger relationships, and greater confidence in the day-to-day struggles of living with serious mental health conditions. The lessons learned from its practical effects—clarity of thought, lighter impact on weight, and flexible dosing—should guide both clinical decisions and public conversations about mental illness care. As always, the best future for mental health combines medication, support, honest communication, and steadfast hope.